THLD: Threshold’s Provides an Update on its Phase I/II Trial using TH-302 in Glioblastoma

Press/Media: Press / Media

PeriodNov 17 2014

Media coverage

1

Media coverage

  • TitleTHLD: Threshold’s Provides an Update on its Phase I/II Trial using TH-302 in Glioblastoma
    Media name/outletYahoo! Finance
    CountryUnited States
    Date11/17/14
    PersonsAndrew Brenner